R-Biopharm announces test to detect monkeypox virus
Darmstadt, Germany, June 1, 2022 – R-Biopharm AG, a leading and globally operating biotechnology company based in Germany, will soon launch a test for the detection of monkeypox virus. The real-time PCR test, developed for research purposes (RUO), shall contribute to track and control the epidemiological spread of the virus. The product is expected to […]
Read More